Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for the norethindrone/ethinyl estradiol/ferrous fumarate oral contraceptive manufactured by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (norethindrone, ethinyl estradiol, and ferrous fumarate)

Snippet

SUPPL AP for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)